European Medicines Agency establishes Geriatric Expert Group
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has established a Geriatric Expert Group, to provide scientific advice on issues related to the elderly.
The group's mandate, objectives and rules of procedure , published today, explain that the group will contribute to the work of the CHMP and the Agency secretariat by:
- giving input on guidelines under consultation;
- giving advice on geriatric aspects of the development, assessment or safety monitoring of medicines;
- taking part in meetings where expertise on geriatrics is needed;
- contributing to the geriatric implementation plan.
The group is formed of nine members with expertise in the scientific and regulatory aspects of geriatrics. It will meet virtually on an ad-hoc basis as required, communicating by e-mail, telephone conference or web conference only.
The establishment of the group forms a major step in the implementation of the Agency's geriatric medicines strategy , adopted in February 2011 as part of the implementation of the Agency's Road Map to 2015.